SD Biosensor, Inc. (KRX:137310)
South Korea · Delayed Price · Currency is KRW 8,200.00
+310.00 (3.93%)
At close: Apr 10, 2026
SD Biosensor Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 710,581 | 694,574 | 655,677 | 2,932,001 | 2,929,961 |
Other Revenue | -0 | - | -0 | - | - |
| 710,581 | 694,574 | 655,677 | 2,932,001 | 2,929,961 | |
Revenue Growth (YoY) | 2.31% | 5.93% | -77.64% | 0.07% | 73.77% |
Cost of Revenue | 389,132 | 357,603 | 533,227 | 1,541,891 | 1,336,785 |
Gross Profit | 321,449 | 336,971 | 122,449 | 1,390,110 | 1,593,176 |
Selling, General & Admin | 221,260 | 194,593 | 206,811 | 169,176 | 177,655 |
Research & Development | 78,053 | 87,946 | 64,203 | 45,762 | 19,086 |
Amortization of Goodwill & Intangibles | 84,020 | 86,506 | 76,257 | 4,443 | 506.34 |
Other Operating Expenses | 6,938 | 3,229 | 2,810 | 3,527 | 1,571 |
Operating Expenses | 404,302 | 391,442 | 370,534 | 243,486 | 205,443 |
Operating Income | -82,853 | -54,471 | -248,085 | 1,146,624 | 1,387,733 |
Interest Expense | -108,226 | -68,589 | -49,228 | -994.06 | -488.66 |
Interest & Investment Income | 24,226 | 22,304 | 23,487 | 26,486 | 6,702 |
Earnings From Equity Investments | -12,205 | - | - | - | - |
Currency Exchange Gain (Loss) | 28,590 | 30,876 | -22,710 | 92,362 | 65,296 |
Other Non Operating Income (Expenses) | -19,209 | -2,221 | -44,224 | -12,500 | -3,359 |
EBT Excluding Unusual Items | -169,677 | -72,101 | -340,759 | 1,251,979 | 1,455,883 |
Gain (Loss) on Sale of Investments | -2,365 | -15,910 | 3,059 | 547.95 | 12,282 |
Gain (Loss) on Sale of Assets | 7,694 | 4,092 | -1,045 | -1,804 | -1,373 |
Asset Writedown | -753,790 | -135,262 | -99,869 | -8,634 | -2,283 |
Pretax Income | -918,139 | -219,181 | -438,614 | 1,242,088 | 1,464,509 |
Income Tax Expense | -404,750 | -121,041 | 29,290 | 333,300 | 376,385 |
Earnings From Continuing Operations | -513,389 | -98,140 | -467,904 | 908,789 | 1,088,124 |
Minority Interest in Earnings | 1,283 | -271.22 | 192.56 | 2,574 | 346.26 |
Net Income | -512,106 | -98,411 | -467,712 | 911,362 | 1,088,471 |
Net Income to Common | -512,106 | -98,411 | -467,712 | 911,362 | 1,088,471 |
Net Income Growth | - | - | - | -16.27% | 76.80% |
Shares Outstanding (Basic) | 120 | 122 | 111 | 101 | 98 |
Shares Outstanding (Diluted) | 120 | 122 | 111 | 101 | 98 |
Shares Change (YoY) | -2.10% | 10.27% | 9.44% | 3.87% | 4.28% |
EPS (Basic) | -4279.00 | -805.00 | -4218.95 | 8996.76 | 11161.38 |
EPS (Diluted) | -4279.00 | -805.00 | -4219.00 | 8996.76 | 11161.00 |
EPS Growth | - | - | - | -19.39% | 69.54% |
Free Cash Flow | 300,431 | 77,744 | -384,884 | 587,008 | 1,044,892 |
Free Cash Flow Per Share | 2510.30 | 635.94 | -3471.82 | 5794.81 | 10714.52 |
Gross Margin | 45.24% | 48.52% | 18.68% | 47.41% | 54.37% |
Operating Margin | -11.66% | -7.84% | -37.84% | 39.11% | 47.36% |
Profit Margin | -72.07% | -14.17% | -71.33% | 31.08% | 37.15% |
Free Cash Flow Margin | 42.28% | 11.19% | -58.70% | 20.02% | 35.66% |
EBITDA | 51,414 | 87,222 | -110,543 | 1,187,444 | 1,406,848 |
EBITDA Margin | 7.23% | 12.56% | -16.86% | 40.50% | 48.02% |
D&A For EBITDA | 134,266 | 141,694 | 137,541 | 40,820 | 19,115 |
EBIT | -82,853 | -54,471 | -248,085 | 1,146,624 | 1,387,733 |
EBIT Margin | -11.66% | -7.84% | -37.84% | 39.11% | 47.36% |
Effective Tax Rate | - | - | - | 26.83% | 25.70% |
Advertising Expenses | 6,914 | 4,476 | 5,988 | 14,830 | 10,329 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.